Drug stores should leave their past behind
Imagine, if you can, a drug store without a pharmacy. Once upon a not-so-distant time, many chain drug stores opened without pharmacies, calling themselves health and beauty aid stores.
Opinion
At-home diagnostics offers ‘a lucrative opportunity’
At-home diagnostic testing has grown from a nascent pre-pandemic trend to an emerging, high-growth health product category in the pandemic’s wake. The accelerated adoption of over-the-counter COVID-19 rapid antigen tests used for at-home self-testing was the tipping point.
Amazon’s RxPass part of a bigger picture
By now it has become a familiar refrain: Amazon is taking another step to extend its reach in the $4 trillion health care sector.
Some relatively easy industry predictions
The new year has been under way for about a month now, and speculation about the upcoming 12 months already abounds. Not to be left at the starting gate, here’s a look from Chain Drug Review’s headquarters into what just might happen between now and December 31 and what will remain anyone’s guess.
Pharmacists can fill a gap in care for rare diseases
How could an economic downturn in 2023 impact the most vulnerable patients? If we look at lessons from past recessions, we see that increases in unemployment, inflation and financial stress significantly impact access to medicines.
The culture wars are coming to drug chains
including the two biggest, CVS Health and Walgreens Boots Alliance — will soon find themselves caught in the middle of the nation’s culture wars, having been thrust into the debate over abortion rights by a recent shift in policy at the
Donigan’s exit raises questions
The new year has gotten off with a stunning development, at least for those with no inside knowledge of chain drug retailing. Heyward Donigan, Rite Aid’s chief executive, announced she is leaving the company she joined three years ago.
CVS award spurs fond memories
As a former CVS executive, I took great pleasure in reading about Katie Pouliot, pharmacy manager of CVS Store 212 in Cranston, R.I. Pouliot received the 2022 Paragon Award from CVS Health.
Health Care Outlook 2023: Sandra Hanna, Neighbourhood Pharmacies
A key takeaway for our federal and provincial governments in Canada throughout the pandemic was that no matter how daunting, community pharmacy rose to the challenge and delivered.
Health Care Outlook 2023: Micah Cost, PQA
As we look toward 2023 and a sense of normalcy that has eluded us for the past few years, there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care.
Health Care Outlook 2023: Sheila Arquette, NASP
Specialty pharmacy continues to be dynamic, demanding and disruptive, undergoing rapid and dramatic change.
Health Care Outlook 2023: Scott Melville, CHPA
Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection.
Health Care Outlook 2023: Peter Matz, FMI
As the COVID-19 pandemic enters its third year, the public health emergency (PHE) declaration that has underpinned the country’s COVID-19 response efforts by providing the federal government with emergency powers, regulatory flexibilities and additional resources is currently set to expire in early
Heath Care Outlook 2023: Susan Cantrell, AMCP
It is easy for those who are not health care professionals to overlook the tremendous potential for innovation in our field today. Similarly, anyone who is not a health policy wonk might not see the important ways policy is evolving to improve the delivery of care for millions of patients.
Health Care Outlook 2023: Ilisa Bernstein, APhA
The pharmacy profession and patient care services delivered by the pharmacy team have evolved significantly over the past few years, bringing new opportunities and challenges.